Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Evidence from the STEP 1 trial In a double-blind trial involving 1961 adults with obesity or overweight without diabetes, once-weekly semaglutide 2.4 mg combined with lifestyle intervention produced substantially greater weight loss than placebo over 68 weeks
PlexusDx medications serve patients seeking long-term GLP-1 therapy as a sustainable approach to weight management alongside lifestyle modifications
By month 6, expect 10-15% total body weight loss if following the combined protocol with adequate protein and exercise
My dogs especially love it too
A synthetic version was created in the years after, but it took until 2005 for this GLP-1 agonist to become an FDA-approved treatment for type 2 diabetes
US$ 20.67
US$ 26.56
US$ 24.10
US$ 22.44
US$ 28.31
US$ 22.65
US$ 27.83
US$ 23.89
US$ 27.73
